Jump to navigation Jump to search

WikiDoc Resources for Leukapheresis


Most recent articles on Leukapheresis

Most cited articles on Leukapheresis

Review articles on Leukapheresis

Articles on Leukapheresis in N Eng J Med, Lancet, BMJ


Powerpoint slides on Leukapheresis

Images of Leukapheresis

Photos of Leukapheresis

Podcasts & MP3s on Leukapheresis

Videos on Leukapheresis

Evidence Based Medicine

Cochrane Collaboration on Leukapheresis

Bandolier on Leukapheresis

TRIP on Leukapheresis

Clinical Trials

Ongoing Trials on Leukapheresis at Clinical Trials.gov

Trial results on Leukapheresis

Clinical Trials on Leukapheresis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Leukapheresis

NICE Guidance on Leukapheresis


FDA on Leukapheresis

CDC on Leukapheresis


Books on Leukapheresis


Leukapheresis in the news

Be alerted to news on Leukapheresis

News trends on Leukapheresis


Blogs on Leukapheresis


Definitions of Leukapheresis

Patient Resources / Community

Patient resources on Leukapheresis

Discussion groups on Leukapheresis

Patient Handouts on Leukapheresis

Directions to Hospitals Treating Leukapheresis

Risk calculators and risk factors for Leukapheresis

Healthcare Provider Resources

Symptoms of Leukapheresis

Causes & Risk Factors for Leukapheresis

Diagnostic studies for Leukapheresis

Treatment of Leukapheresis

Continuing Medical Education (CME)

CME Programs on Leukapheresis


Leukapheresis en Espanol

Leukapheresis en Francais


Leukapheresis in the Marketplace

Patents on Leukapheresis

Experimental / Informatics

List of terms related to Leukapheresis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Leukapheresis is a laboratory procedure in which white blood cells are separated from a sample of blood. This may be done to decrease a very high white blood cell count in individuals with cancer (leukemia) or to remove white blood cells for transfusion. In the case of cancer, usually hematological malignancies such as acute leukemias, there are white blood cell counts high enough to cause hemostasis and "sludging" in the capillaries. This can effect retinal vasculature leading to vision changes, pulmonary vasculature leading to shortness of breath from decreased efficiency in oxygen exchange, as well as other organ systems such as the brain which would become clinically apparent with neurological deterioration of a patient from cerebrovascular compromise.

Alternatively, only granulocytes, macrophages and monocytes can be removed, leaving the lymphocyte count largely unchanged. This is used as a treatment for autoimmune diseases such as ulcerative colitis and rheumatoid arthritis, where these cells play an active part in the inflammation process.


  • G Hahn, B Stuhlmüller, N Hain, J R Kalden, K Pfizenmaier, and G R Burmester (1993). "Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy". The Journal of Clinical Investigation. 91: 862–870.
  • National Institute for Health and Clinical Excellence, Leukapheresis for inflammatory bowel disease (guidance). Retrieved Oct. 06 2005

Template:WikiDoc Sources